Rachel M Yoder - The University of Kansas Cancer Center

基本信息

Career Trajectory

Bio

Clinical and translational work in breast cancer, emphasis on triple-negative breast cancer. Approaches: (1) Evaluating safety and efficacy of novel/repurposed anti-cancer drugs, (2) Establishing link between biomarkers and patterns of response and recurrence.

Research Interests

Papers共 36 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Predictors of Immunotherapy Response in Triple Negative Breast Cancer

Yiduo Hu,Rachel Yoder,Priyanka Sharma

Current Breast Cancer Reportsno. 1 (2025): 1-14

Cited0Views0Bibtex

SMARCA2 Compensation of SMARCA4 Loss Mediates Adaptive Resistance to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer: Paired Transcriptomic Analysis of Pre- and Post-Treatment Samples from NeoSTOP and NeoPACT

Shane Stecklein,Rachel Yoder,Joshua Staley,Zachary Schmitt,Anne O'Dea,Lauren Nye,Deepti Satelli,Gregory Crane,Rashna Madan,Maura O'Neil,Andrew Godwin,Harsh Pathak,Qamar Khan,Joyce O'Shaughnessy,Priyanka Sharma

CANCER RESEARCH（2024）

Cited0Views0Bibtex

Orphan Noncoding RNA (oncrna) Liquid Biopsy Assay is Prognostic for Survival in Patients with Triple-Negative Breast Cancer (TNBC) and Residual Disease

Rachel Yoder,Jennifer Yen,Mehran Karimzadeh,Joshua M. Staley, India Fernandez, Adam C. Heinrich,Fereydoun Hormozdiari,Jeffrey Gregg,Andrew K. Godwin,Irene Acerbi, Raaj Trivedi,Babak Alipanahi,Shane R. Stecklein,Priyanka Sharma

CANCER RESEARCH（2024）

Cited0Views0Bibtex

NeoTRACT: Phase II Trial of Neoadjuvant Tumor Infiltrating Lymphocyte- and Response-Adapted Chemoimmunotherapy for Triple-Negative Breast Cancer (TNBC)

Shane R. Stecklein,Allison Aripoli,Roberto Salgado,Anne O'Dea,Lauren Elizabeth Nye,Kelsey E. Larson,Deepti Satelli, Ryan Rader,Rashna Madan,Rachel Yoder,Joshua M. Staley, India Fernandez, Adam Heinrich,Jamie L. Wagner,Christa Balanoff,Lyndsey Kilgore,Leonidas Bantis,Andrew K. Godwin,Qamar J. Khan,Priyanka Sharma

Journal of Clinical Oncologyno. 16_suppl (2024): TPS629-TPS629

Cited0Views0Bibtex

Abstract PS16-09: Analysis of the Radiosensitivity Index/Genomic-Adjusted Radiation Dose (RSI-GARD) in Paired Pre- and Post-Treatment TNBC Samples: Implications for Biomarker-Guided Radiotherapy

Shane Stecklein, Julia White,Rachel Yoder,Joshua Staley,Zachary Schmitt,Anne O'Dea,Lauren Nye,Deepti Satelli,Gregory Crane,Rashna Madan,Maura O'Neil,Andrew Godwin,Harsh Pathak,Qamar Khan,Joyce O'Shaughnessy,Priyanka Sharma

Cancer Researchno. 9_Supplement (2024): PS16-09

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn